PuraMed BioScience Announces Product Donation at a Sponsorship Level to Operation Gratitude

Jul 08, 2014, 09:11 ET from PuraMed BioScience, Inc.

SCHOFIELD, Wis., July 8, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is now a corporate sponsor of Operation Gratitude.

"This partnership opportunity allows us to provide our fast-acting, migraine headache relief product, LipiGesic® M, to our active-duty service men and women," said Russ Mitchell, Chairman and CEO of PuraMed BioScience. "Based on our feedback from Honoring Our Troops, we know that LipiGesic M will be well received in the care packages sent to our deployed military men and women. It relieves migraine pain fast, and it's easy to use."

Each year, Operation Gratitude provides more than 150,000 care packages filled with hygiene, entertainment, hand-made items, snacks, and personal letters of appreciation to veterans, first responders, recruits, wounded warriors, caregivers, and US service men and women deployed overseas. Each package is valued between $75 to $100.

"Our goal is to show appreciation to those people who serve or have served in the military and at the same time provide opportunities for community members to express their gratitude," said Dana Chotiner, Director of Corporate Relations and Special Events for Operation Gratitude. "We rely on the generosity of companies, communities, and individuals to not only supply the items, but to donate the $15 needed to ship each package. PuraMed's product donation helps us fulfill that mission."

"This is one more way that we can reach out to our service men and women," said Mitchell. "We are happy that LipiGesic M can now get to our military men and women who might experience migraines."

About Operation Gratitude

Operation Gratitude annually sends 150,000+ care packages filled with snacks, entertainment, hygiene and hand-made items, plus personal letters of support, to veterans, first responders, wounded warriors, caregivers and to individually named U.S. service members deployed overseas. Our mission is to lift the spirits and meet the evolving needs of our active-duty and veteran communities, and provide volunteer opportunities for all Americans to express their appreciation to members of our military. Each package contains donated product valued at $75-100 and costs the organization $15 to assemble and ship. Since its inception in 2003, Operation Gratitude volunteers have shipped more than One Million Care Packages. http://www.operationgratitude.com/

About LipiGesic M

LipiGesic M is a clinically tested, over-the-counter, homeopathic medication formulated with feverfew and ginger that has been shown to work as well as prescription migraine medication without drowsiness. LipiGesic M is easy to use. The pre-packaged UnitDose delivers the pre-measured dose of LipiGesic M under the tongue where is it absorbed quickly into the bloodstream. When LipiGesic M is taken according directions at the first sign of a migraine, many users report that they can feel relief in minutes. http://www.lipigesic.com/about

Migraine affects service men and women across all branches of the military. Over the past decade, migraines and other headaches have become a significant problem for the U.S. Armed Forces. For more information on the incidence of migraine in the military, click here.

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to LipiGesic M, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory and anxiolytic products as it moves forward in the development of its hemp-based CBD product line. http://www.puramedbioscience.com/

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

PuraMed BioScience, Inc.
Russ Mitchell, Chairman and CEO

SOURCE PuraMed BioScience, Inc.